Candel Therapeutics (CADL) Profit After Tax (2020 - 2023)
Historic Profit After Tax for Candel Therapeutics (CADL) over the last 4 years, with Q4 2023 value amounting to -$11.1 million.
- Candel Therapeutics' Profit After Tax fell 11801.93% to -$11.1 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$37.9 million, marking a year-over-year decrease of 10155.1%. This contributed to the annual value of -$55.2 million for FY2024, which is 4549.67% down from last year.
- Latest data reveals that Candel Therapeutics reported Profit After Tax of -$11.1 million as of Q4 2023, which was down 11801.93% from -$8.4 million recorded in Q3 2023.
- In the past 5 years, Candel Therapeutics' Profit After Tax registered a high of $1.6 million during Q4 2021, and its lowest value of -$17.1 million during Q2 2021.
- In the last 4 years, Candel Therapeutics' Profit After Tax had a median value of -$8.4 million in 2023 and averaged -$7.3 million.
- In the last 5 years, Candel Therapeutics' Profit After Tax skyrocketed by 11523.19% in 2021 and then plummeted by 87777.78% in 2023.
- Over the past 4 years, Candel Therapeutics' Profit After Tax (Quarter) stood at -$10.5 million in 2020, then surged by 115.23% to $1.6 million in 2021, then plummeted by 418.86% to -$5.1 million in 2022, then plummeted by 118.02% to -$11.1 million in 2023.
- Its Profit After Tax was -$11.1 million in Q4 2023, compared to -$8.4 million in Q3 2023 and -$9.6 million in Q2 2023.